LC
LifeSci Capital Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1
Tourmaline Bio
TRML
$1.22B
| $47.60 | $48 |
1%
upside
| Market Perform |
9 Sep ‘25
yesterday |
|
|
2
Revolution Medicines
RVMD
$7.56B
| $40.45 | $80 |
98%
upside
| Outperform |
18 Aug ‘25
23 days ago |
|
|
|
PVLA
3
Palvella Therapeutics, Inc. Common Stock
PVLA
$661M
|
SS
Sam Slutsky
| $59.73 | $90 |
51%
upside
| Outperform |
4 Aug ‘25
1 month ago |
|
|
ABVX
4
Abivax
ABVX
$6.62B
|
SS
Sam Slutsky
| $87.63 | $101 |
15%
upside
| Outperform |
23 Jul ‘25
1 month ago |
|
5
RAPT Therapeutics
RAPT
$234M
| $14.14 | $31 |
119%
upside
| Outperform |
22 Jul ‘25
1 month ago |
|
|
|
CBIO
6
Crescent Biopharma, Inc. Common Stock
CBIO
$170M
|
CZ
Charles Zhu
| $12.23 | $22 |
80%
upside
| Outperform |
18 Jun ‘25
2 months ago |
|
|
TECX
7
Tectonic Therapeutic, Inc. Common Stock
TECX
$324M
| $17.31 | $87 |
403%
upside
| Outperform |
6 Jun ‘25
3 months ago |
|
|
8
Monte Rosa Therapeutics
GLUE
$296M
| $4.80 | $19 |
296%
upside
| Outperform |
12 Mar ‘25
6 months ago |
|
|
|
MOLN
9
Molecular Partners
MOLN
$144M
| $3.85 | $12 |
212%
upside
| Outperform |
11 Mar ‘25
6 months ago |
|
|
10
Immunome
IMNM
$783M
| $9 | $20 |
122%
upside
| Outperform |
11 Mar ‘25
6 months ago |
|
|
11
Protara Therapeutics
TARA
$120M
| $3.11 | $22 |
607%
upside
| Outperform |
11 Mar ‘25
6 months ago |
|
|
12
Zymeworks
ZYME
$1.15B
| $15.19 | $30 |
98%
upside
| Outperform |
11 Mar ‘25
6 months ago |
|
|
|
13
Tourmaline Bio
TRML
$1.22B
|
JS
Jimmy Shan
| $47.60 | $58 |
22%
upside
| Outperform |
24 Feb ‘25
6 months ago |
|
|
MREO
14
Mereo BioPharma
MREO
$283M
|
CJ
Cory Jubinville
| $1.78 | $10 |
462%
upside
| Outperform |
24 Dec ‘24
8 months ago |
|
15
Liquidia Corp
LQDA
$2.35B
|
CJ
Cory Jubinville
| $27.29 | $30 |
10%
upside
| Outperform |
3 Oct ‘24
11 months ago |
|
|
ORKA
16
Oruka Therapeutics, Inc. Common Stock
ORKA
$591M
| $15.77 | $41 |
160%
upside
| Outperform |
16 Sep ‘24
11 months ago |
|
|
17
Celcuity
CELC
$2.37B
|
OM
Oliver McCammon
| $55.93 | $27 |
52%
downside
| Outperform |
26 Aug ‘24
1 year ago |
|
|
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.54B
|
PD
Patrick Dolezal
| $15.81 | $26 |
64%
upside
| Outperform |
2 May ‘23
2 years ago |
|